FAQs about Health » Cardiology » Lipid Disorders

News about Health » Cardiology » Lipid Disorders

CRISPR Gene Editing Therapy CTX310 Lowers LDL-C and Triglycerides in Lipid Disorders - HCPLive [Visit Site | Read More]

Stony Brook Heart Institute Delivers World’s First Commercial Plozasiran Treatment for Patients with Rare Lipid Disease - SBU News [Visit Site | Read More]

Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases - Nature [Visit Site | Read More]

Interplay between lipid droplets and alpha-synuclein: implication in Parkinson’s disease pathogenesis - Frontiers [Visit Site | Read More]